CA2335791A1 - Alkylamines et leurs precurseurs, utilises comme modulateurs specifiques de la fonction des lymphocytes t gamma-delta humains - Google Patents

Alkylamines et leurs precurseurs, utilises comme modulateurs specifiques de la fonction des lymphocytes t gamma-delta humains Download PDF

Info

Publication number
CA2335791A1
CA2335791A1 CA002335791A CA2335791A CA2335791A1 CA 2335791 A1 CA2335791 A1 CA 2335791A1 CA 002335791 A CA002335791 A CA 002335791A CA 2335791 A CA2335791 A CA 2335791A CA 2335791 A1 CA2335791 A1 CA 2335791A1
Authority
CA
Canada
Prior art keywords
alkylamine
cells
straight
delta
gamma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002335791A
Other languages
English (en)
Inventor
Jack F. Bukowski
Michael B. Brenner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2335791A1 publication Critical patent/CA2335791A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

L'invention concerne des techniques et des compositions qui permettent d'induire la prolifération des lymphocytes T V.gamma.2V.delta.2. Ces compositions contiennent des agents à base d'alkylamine, tels que des alkylamines et des précurseurs d'alkylamines. Ces agents sont également utiles pour activer le récepteur des lymphocytes T .gamma..delta..
CA002335791A 1998-06-30 1999-06-24 Alkylamines et leurs precurseurs, utilises comme modulateurs specifiques de la fonction des lymphocytes t gamma-delta humains Abandoned CA2335791A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9119798P 1998-06-30 1998-06-30
US60/091,197 1998-06-30
PCT/US1999/014303 WO2000000158A2 (fr) 1998-06-30 1999-06-24 Alkylamines et leurs precurseurs, utilises comme modulateurs specifiques de la fonction des lymphocytes t gamma-delta humains

Publications (1)

Publication Number Publication Date
CA2335791A1 true CA2335791A1 (fr) 2000-01-06

Family

ID=22226564

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002335791A Abandoned CA2335791A1 (fr) 1998-06-30 1999-06-24 Alkylamines et leurs precurseurs, utilises comme modulateurs specifiques de la fonction des lymphocytes t gamma-delta humains

Country Status (5)

Country Link
EP (1) EP1090106A2 (fr)
JP (1) JP2002519007A (fr)
AU (1) AU5205999A (fr)
CA (1) CA2335791A1 (fr)
WO (1) WO2000000158A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767714B2 (en) 2002-02-18 2010-08-03 Ajinomoto Co., Inc. Method of preventing infectious diseases
ATE340569T1 (de) * 2002-02-18 2006-10-15 Ajinomoto Kk Verwendung eines neuen mittels zur verhütung von infektionen
EP1426052B1 (fr) * 2002-12-02 2009-09-02 Innate Pharma Compositions contenant de l'interleukine-2 et un composé activant les cellules T gamma delta, et leurs utilisations
EP1767200A4 (fr) * 2004-06-15 2007-08-15 Osaka Prefecture Agent anti-vieillissement

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3574859A (en) * 1968-07-05 1971-04-13 Carl M Kosti Process for the treatment of hypertrophied gums
US4153679A (en) * 1972-04-18 1979-05-08 Wilkinson Sword Limited Acyclic carboxamides having a physiological cooling effect
US4242359A (en) * 1977-04-01 1980-12-30 Cornell Research Foundation, Inc. Spermicidal agents
US5340921A (en) * 1986-07-03 1994-08-23 T Cell Sciences, Inc. Γ, δT cell receptor and methods and detection
US5679347A (en) * 1992-12-10 1997-10-21 Brigham And Women's Hospital Methods of isolating CD1-presented antigens, vaccines comprising CD1-presented antigens, and cell lines for use in said methods
US5639653A (en) * 1993-07-19 1997-06-17 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva Universtiy Method for proliferating Vγ2Vδ2 T cells

Also Published As

Publication number Publication date
EP1090106A2 (fr) 2001-04-11
WO2000000158A3 (fr) 2000-11-16
AU5205999A (en) 2000-01-17
JP2002519007A (ja) 2002-07-02
WO2000000158A9 (fr) 2000-06-22
WO2000000158A2 (fr) 2000-01-06

Similar Documents

Publication Publication Date Title
Mizoguchi et al. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation
Chen et al. Glatiramer acetate induces a Th2-biased response and crossreactivity with myelin basic protein in patients with MS
US20110281950A1 (en) Compositions and methods for reducing proliferation and viability of lymphoblastoid cells
AU2009208390B2 (en) A method of inducing tolerance to an allergen
Guryanova et al. Strategies for using muramyl peptides-modulators of innate immunity of bacterial origin-in medicine
JPH0625006A (ja) 免疫障害、炎症および慢性感染症を治療するための方法および組成物
RU2415920C2 (ru) Применение специфических молочнокислых бактерий для получения композиции, пригодной для стимуляции иммунного ответа при заболеваниях, связанных с изменениями в иммунной системе
US20120244212A1 (en) Enhanced method and composition for the treatment of hiv+ tuberculosis patients with anti-retroviral drugs and liposomal encapsulation for delivery of reduced glutathione
CA2391499A1 (fr) Compositions et methodes pour le traitement des troubles allergiques
JPH05508663A (ja) 哺乳動物における異系移植片拒否反応を抑制するための方法と組成物
AU2003250892A1 (en) Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors
Taniguchi et al. Antilymphocyte immunoglobulins stimulate peripheral blood lymphocytes to proliferate and release lymphokines
CN107582566B (zh) 通过多胺化合物调控自身免疫性疾病的方法和组合物
Chabot et al. Cytokine production in T lymphocyte-microglia interaction is attenuated by glatiramer acetate: a mechanism for therapeutic efficacy in multiple sclerosis
WO2009137821A1 (fr) Utilisation de lysophospholipides pour traiter l'inflammation
Kaneko et al. Role of tumour necrosis factor-alpha (TNF-α) in the induction of HIV-1 gp120-mediated CD4+ T cell anergy
CA2335791A1 (fr) Alkylamines et leurs precurseurs, utilises comme modulateurs specifiques de la fonction des lymphocytes t gamma-delta humains
CN1087278A (zh) 溶菌酵素二聚体的新用途及其含有溶菌酵素二聚体的制剂
EP4081246B1 (fr) Composition de traitement ou de prévention d'une allergie ou d'une réaction allergique
JP6708376B2 (ja) ＩＦＮ−γ及び／又はＩＬ−１７の産生抑制剤、並びにＴｈ１細胞及び／又はＴｈ１７細胞の分化抑制剤
Wang et al. Effects of IL-10 on OX62, MHC-II and CD86 in bone marrow DCs in rats with organophosphate poisoning
Auci et al. Synergy of transforming growth factor beta 1 and all trans retinoic acid in the treatment of inflammatory bowel disease: role of regulatory T cells
Walrand et al. The role of nutrition in immunity of the aged
HU217966B (hu) Hidroxi-klorokin alkalmazása a transzplantátum gazdaszervezettel szembeni reakciójának kezelésére alkalmas gyógyszerkészítmény előállítására
WO2022080249A1 (fr) Agent pour prévenir ou améliorer les affections inflammatoires de l'intestin

Legal Events

Date Code Title Description
FZDE Dead